Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Journal of Surgical Oncology|August 1, 1990
Adjuvant chemotherapy and scar irradiation in breast cancerF Içli, D Dinçol, E Isikman, et al.Cytokine|July 6, 2000
Diurnal variations of serum GM-CSF levelsD Dinçol, H Akbulut, A Büyükçelik, et al.Journal of Surgical Oncology|August 1, 1992
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancerF Içli, N Günel, D Dinçol, et al.Medical Oncology (Northwood, London, England)|August 24, 1999
Concurrent occurrence of three neoplasms including non-Hodgkin's lymphoma, renal cell carcinoma and leiomyoma in the same kidneyD Dinçol, A Arican, A Ensari, et al.Journal of Surgical Oncology|April 1, 1997
Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancerF Içli, H Karaoguz, H Akbulut, et al.Journal of Surgical Oncology|December 1, 1992
Primary gastrointestinal lymphomas in Turkey: a retrospective analysis of clinical features and results of treatmentD Dinçol, F Içli, S Erekul, et al.Nuclear Medicine Communications|April 21, 2001
Value of combined 67Ga and 99Tc(m)-human immunoglobulin G whole-body scanning in malignant lymphomaN O Küçük, G Aras, A Soylu, et al.Oncology|September 1, 1997
Results of the cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) +/- bleomycin treatment and evaluation of prognostic factors in aggressive lymphomas in TurkeyD Dinçol, H Akbulut, F Içli, et al.Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesotheliomaS Emri, H Akbulut, F Zorlu, et al.Cancer|July 15, 1993
Severe vascular toxicity associated with cisplatin-based chemotherapyF Içli, H Karaoğuz, D Dinçol, et al.Pageof 2